Development and validation of an HPLC-UV method for the determination of gatifloxacin in bulk material, pharmaceutical formulations, human plasma and metal complexes.

Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi.
Pakistan journal of pharmaceutical sciences (Impact Factor: 0.68). 11/2006; 19(4):275-81.
Source: PubMed


A simple reversed phase HPLC method was developed for the quantitative determination of gatifloxacin (GTX) in the bulk material, pharmaceutical formulations and human serum using Mediterranea C18 (25 x 0.46 mm, 5 mm) column. The mobile phase, acetonitrile, methanol and water (40:40:20 v/v pH 2.7 adjusted by phosphoric acid), was delivered at a flow rate of 1.0 ml/min. The eluent was monitored using spectrophotometric detection at 286 nm. The method is specific to GTX and able to resolve the drug peak from formulation excipients and metal impurities. The method is accurate (99.18-101.87%), precise (intra-day variation 0.14-1.67% and inter-day variation 0.32-1.80%) and linear within the range 0.1-25 microg/ml (R2=0.999) concentration and was successfully used in monitoring left over drug in drug-metal complexes. The detection limit of GTX at a signal-to-noise ratio of 3 was 1.73 ng/ml in human plasma while quantification limit in human serum was 5.77 ng/ml. The proposed method is applicable to routine analysis of GTX in pharmaceutical formulations as well as in human plasma samples.

Download full-text


Available from: Najma Sultana,
  • Source
    • "Gatifloxacin was assayed in plasma by reversephase high performance liquid chromatography (HPLC), using a reported assay with minor modifications (Najma Sultana et al., 2006; Santoro et al., 2006). The HPLC system (Laballiance, USA) comprised a quaternary gradient solvent delivery pump (model AIS 2000) and UV detector (model 500). "
    [Show abstract] [Hide abstract]
    ABSTRACT: 1. The pharmacokinetics of gatifloxacin were investigated following intravenous and oral administration of a single dose at a rate of 10 mg/kg body weight in broiler chicks. 2. Drug concentration in plasma was determined using High Performance Liquid Chromatography with ultraviolet detection on samples collected at frequent intervals after drug administration. 3. Following intravenous administration, the drug was rapidly distributed (t(1/2α): 0·33 ± 0·008 h) and eliminated (t(1/2β): 3·62 ± 0·03 h; Cl(B): 0·48 ± 0·002 l/h/kg) from the body. 4. After oral administration, the drug was rapidly absorbed (C (max): 1·74 ± 0·024 µg/mL; T (max): 2 h) and slowly eliminated (t(1/2β): 3·81 ± 0·07 h) from the body. The apparent volume of distribution (V(d(area))), total body clearance (Cl(B)) and mean residence time (MRT) were 3·61 ± 0·04 l/kg, 0·66 ± 0·01 l/h/kg and 7·16 ± 0·08 h, respectively. The oral bioavailability of gatifloxacin was 72·96 ± 1·10 %. 5. Oral administration of gatifloxacin at 10 mg/kg is likely to be highly efficacious against susceptible bacteria in broiler chickens.
    British Poultry Science 04/2012; 53(2):257-61. DOI:10.1080/00071668.2012.682724 · 0.94 Impact Factor
  • Source
    • "Birds were sacrificed at 12 hours after the last dose of the drug to collect the samples of liver and skeletal muscle. The drug concentration in tissue samples was determined by HPLC assay (Santoro et al., 2006 and Najma Sultana et al., 2006). "

    01/2012; 2(1).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin® for the treatment of respiratory tract infections..
    Profiles of Drug Substances, Excipients and Related Methodology 01/2012; 37:183-243. DOI:10.1016/B978-0-12-397220-0.00005-2
Show more